Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
German medicines watchdog rejects ‘new tenofovir’ pill

The German health technology assessment agency IQWiG has announced that it finds no advantage in Descovy, a combination pill containing a new version of the HIV

Published
22 August 2016
By
Gus Cairns
German agency criticises European programme for speeding some drug approvals

In pointed remarks, Germany’s cost-effectiveness watchdog has criticised an effort by European regulators to accelerate approval for new medicines by limiting its requirements for evidence. The concerns raised by the agency come as regulators on both side of the Atlantic increasingly look to such approaches to get new drugs to patients with unmet medical needs. At issue is a proposal called adaptive pathways, a term used to describe a method for jumpstarting drug approvals for select patient populations. Two years ago,an EMA pilot programme was launched to compare initial data used for approval with so-called “real world” data, which is subsequently gathered after the medicines are in use.

Published
18 August 2016
From
STAT
Do trade deals threaten India as low-cost HIV drug maker?

We wondered if it’s true that the next round of agreements, both those that involve the United States and those that don’t, would undermine some large drug makers in India.

Published
09 August 2016
From
Politifact
People At High Risk Of HIV Are Having The HIV Prevention Pill Taken From Them

Exclusive: The NHS is stopping participants in a major study into the drug Truvada from having further access to it – a move which Britain’s biggest HIV charity said would lead some to become infected.

Published
29 July 2016
From
Buzzfeed
NHS England tried to sabotage hepatitis C drugs release because it couldn't afford them, doctors claim

NHS England tried to sabotage the release of hepatitis C drugs because it couldn't afford them, it has been claimed. Under current procedures, drugs approved by Nice typically become widely available to NHS patients after a statutory period of 90 days. However, the BMJ claims: “In an apparent panic over high prices and affordability, NHS England deployed many delaying tactics to block timely access to the hepatitis C drugs.”

Published
28 July 2016
From
The Independent
South Africa: All HIV Positive Inmates to Receive Treatment

All HIV positive inmates in South Africa's correctional centres will from September this year receive life-saving antiretroviral drugs, irrespective of their CD4 count.

Published
22 July 2016
From
AllAfrica
South Africa: Produce HIV Drugs Locally, Says Science Minister

Durban -South Africa should advocate for the creation of local HIV drug manufacturing companies and stop depending on foreign pharmaceutical multinationals for these drugs, says Science and Technology Minister Naledi Pandor.

Published
22 July 2016
From
AllAfrica
WHO Updates Patent Status Info For New Hepatitis C Medicines

The World Health Organization has issued updated information on the patent status of hepatitis C medicines, including assessments of hurdles for affordable generic versions of latest drugs.

Published
21 July 2016
From
Intellectual Property Watch
MSF Calls for Immediate Implementation of Quality HIV Care in Neglected Communities

Global HIV/AIDS leaders at the International AIDS Conference in Durban must develop and implement an action plan to address the critical lack of access to HIV treatment in countries in West and Central Africa where coverage remains below 30 percent, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Tuesday.

Published
21 July 2016
From
MSF
AIDS 2016 Demo: Activists jam Durban’s streets

Up to 5,000 people, including activists and people living and affected by HIV /AIDS marched on Monday July, 18, 2016, jamming the streets of Durban to demand universal treatment, support, funding and care for all people living with HIV. They … more →

Published
19 July 2016
From
Key Correspondents
← First12345...113Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close